|
 |
FDA Approval Activities for this Drug…
Alkeran (mephalan hydrochloride) Injection, SmithKlineBeecham NDA 20-207/S-007 4/29/03 Alkeran (mephalan) Tablets, SmithKlineBeecham NDA 14-691/S-024 5/14/03 7/9/03 Alkeran (mephalan) Tablets 2 mg, and Alkeran (mephalan hydrochloride) Injection, SmithKlineBeecham d/b/a GlaxoSmithKline NDA 14-691/S-023 & 20-207/S-005 1/7/02 2/8/02 ALKERAN (melphalan) Tablets Glaxo Wellcome, NDA 14-691/S-020
For the most up-to-date approval information, please locate this API using the drug index. |
|
|